May 17, 2023

TB Alliance receives up to $3.9M from the Cystic Fibrosis Foundation to further the development of an NTM drug

TB Alliance will advance the research and development of a new compound that could be used to treat infections caused by nontuberculous mycobacteria
May 8, 2023

TB Alliance Statement on United Nations Multi-Stakeholder Hearing on Tuberculosis

Statement from Mel Spigelman, MD, President and CEO, TB Alliance
March 10, 2023

Ratan P. Watal Appointed to the Board of TB Alliance

Ratan Watal’s deep experience will accelerate new TB cures in India
February 23, 2023

Fireside Chat with Bruce Carter

A conversation with outgoing Chair of the TB Alliance Board of Directors
February 20, 2023

SimpliciTB Trial Results Presented at CROI 2023

Clinical Trial for Drug-Sensitive and Drug-Resistant TB Regimen Evaluated Shorter Regimens